Exfoliation syndrome.
Ritch R, Schlötzer-Schrehardt U.
Surv Ophthalmol. 2001 Jan-Feb;45(4):265-315. doi: 10.1016/s0039-6257(00)00196-x.
Pathogenesis and complications of chronic eye rubbing in ocular allergy.
Ben-Eli H, Erdinest N, Solomon A.
Curr Opin Allergy Clin Immunol. 2019 Oct;19(5):526-534. doi: 10.1097/ACI.0000000000000571.
Pseudoexfoliation Syndrome and Glaucoma.
Tuteja S, Zeppieri M, Chawla H.
2023 May 31. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
Exfoliation syndrome.
Ritch R.
Curr Opin Ophthalmol. 2001 Apr;12(2):124-30. doi: 10.1097/00055735-200104000-00008.
Effect of subretinal injection of tissue-type plasminogen activator for the treatment of submacular hemorrhage complicating polypoidal choroidal vasculopathy.
Zheng G, Wang N, Lei W, Xu Y, Xia X, Xiong S.
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2024 Sept 28;49(9):1431-1439. doi: 10.11817/j.issn.1672-7347.2024.230488.
Corneal endothelial assessment with special references to keratoconus.
McMonnies CW.
Optom Vis Sci. 2014 Jun;91(6):e124-34. doi: 10.1097/OPX.0000000000000271.
Ocular and systemic manifestations of exfoliation syndrome.
Ritch R.
J Glaucoma. 2014 Oct-Nov;23(8 Suppl 1):S1-8. doi: 10.1097/IJG.0000000000000119.
Development of a Noninvasive, Laser-Assisted Experimental Model of Corneal Endothelial Cell Loss.
Holzhey A, Sonntag S, Rendenbach J, Ernesti JS, Kakkassery V, Grisanti S, Reinholz F, Freidank S, Vogel A, Ranjbar M.
J Vis Exp. 2020 Apr 24;(158). doi: 10.3791/60542.
Emergent risk factors associated with eyeball loss and ambulatory vision loss after globe injuries.
Hyun Lee S, Ahn JK.
J Trauma. 2010 Jul;69(1):195-8. doi: 10.1097/TA.0b013e3181bbd23b.
Displacement of Submacular Hemorrhage With Subretinal Injection of Recombinant Tissue Plasminogen Activator and Gas Tamponade in the Setting of Myopic Degeneration.
Shields RA, Tang PH, Regillo CD, Silva RA.
Ophthalmic Surg Lasers Imaging Retina. 2019 Apr 1;50(4):257-259. doi: 10.3928/23258160-20190401-11.
